mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.02 |
0.5 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
AZD7762 |
GDSC1000 |
pan-cancer |
AAC |
0.02 |
0.5 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.5 |
mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
Panobinostat |
FIMM |
pan-cancer |
AAC |
-0.07 |
0.6 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.035 |
0.6 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |